| Gesundheit | zyklischer Konsum | ||||
| Grundstoffe |
Abaris Biotechnology Opportunities - A EUR
Fonds
- ErtragsverwendungThesaurierend
- Lfd. Kosten
2,34% - TER
2,32% - Fondsgröße
12,93 Mio. € - WährungEUR
- FWW Fundstars
Branchen
Top 10 Holdings
| Hims & Hers Health Inc. Regist.Shares A DL -,0001 | Viking Therapeutics Inc. Registered Shares DL -,005 | ||||
| Iovance Biotherapeutics Inc. Registered Shares DL -,001 | TransMedics Group Inc. Registered Shares o.N. | ||||
| Viridian Therapeutics Inc. Registered Shares o.N. |
Top Länder
| USA | Cayman Islands | ||||
| Niederlande | Schweiz | ||||
| Israel | Kanada | ||||
| Irland |